Dennis Carney - Concepedia

Author

Dennis Carney

Peter MacCallum Cancer Centre ORCID

Also Known As

D A Carney, D Carney, D. A. Carney, D. Carney, Dennis A Carney, Dennis A. Carney, Dennis Carney

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Monash University The University of Texas MD Anderson Cancer Center The Royal Melbourne Hospital

About

Dennis Carney is an author at Peter MacCallum Cancer Centre specializing in medicine, pathology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	584
2	Health Sciences	8	8	339
3	Cell Biology	2	2	105
4	Engineering	1	1	66
5	Cellular Therapies	1	1	19

Dennis Carney

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease Andrew W. Roberts, John F. Seymour, Jennifer R. Brown, Journal of Clinical Oncology	2011	808
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma Chan Y. Cheah, Kirsten Herbert, Kacey O’Rourke, British Journal of Cancer	2014	129
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy Dennis Carney, David Westerman, Constantine S. Tam, Leukemia Hematological MalignancyFludarabine Combination ChemotherapyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2010	105
OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action Yan Zhou, Celia Garcı́a-Prieto, Dennis Carney, JNCI Journal of the National Cancer Institute	2005	102
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the <scp>BCL</scp>2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory <scp>CD</scp>20<sup>+</sup> lymphoid malignancies Andrew W. Roberts, Ranjana H. Advani, Brad S. Kahl, British Journal of Haematology	2015	98
A Comparison of Whole-Body MRI and CT for the Staging of Lymphoma Darren D. Brennan, Tadhg G. Gleeson, Linda Coate, American Journal of Roentgenology	2005	98
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma Constantine S. Tam, Max Wolf, H. Miles Prince, Cancer	2006	94
Clonal hematopoiesis, myeloid disorders and <i>BAX</i>-mutated myelopoiesis in patients receiving venetoclax for CLL Piers Blombery, Thomas E. Lew, Michael A. Dengler, Blood Hematological MalignancySimultaneous Bcl2 MutationsOncologyAcute Myeloid LeukemiaMalignant Blood Disorder	2021	71
Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy Chan Y. Cheah, Michael S. Hofman, Michael Dickinson, British Journal of Cancer	2013	68
Ultrasound contrast physics: a series on contrast echocardiography, article 3 Marti McCulloch, Cris Gresser, Sally Moos, Journal of the American Society of Echocardiography Medical UltrasoundRadiologyEngineeringMedical ImagingVascular Image	2000	66

Page 1